Status:
COMPLETED
Rapydan Topical Anaesthesia for Arterial Cannulation
Lead Sponsor:
Medical University of Vienna
Collaborating Sponsors:
The Cleveland Clinic
Population Health Research Institute
Conditions:
Arterial Catheterization
Eligibility:
All Genders
18-90 years
Phase:
PHASE4
Brief Summary
Arterial catheterization is painful and is associated with patient stress and anxiety. Analgesia is usually provided by subcutaneous injection of local anesthetic. An alternative is topical anaesthesi...
Detailed Description
Many clinical procedures including arterial and venous punctures, percutaneous venous catheter insertion, lumbar puncture, and dermatological procedures are associated with pain and consequent patient...
Eligibility Criteria
Inclusion
- Patients having elective valve-replacement or coronary artery bypass grafting requiring arterial access before induction of anaesthesia.
Exclusion
- analgesic use within 24 hours before surgery
- injury or infection at the planned puncture site
- known allergy to local anesthetics
- drug abuse
- alcoholism or psychiatric disorders
- childbearing potential without adequate birth control
- abnormal Allen's test
Key Trial Info
Start Date :
March 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT01494311
Start Date
March 1 2011
End Date
October 1 2011
Last Update
March 18 2013
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic Department of Outcomes Research
Cleveland, Ohio, United States, 44195
2
Medical University of Vienna
Vienna, Austria
3
Population Health Research Institute, McMaster University
Hamilton, Ontario, Canada